The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nguer, C. M.
Right arrow Articles by Richard, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nguer, C. M.
Right arrow Articles by Richard, Y.

The Journal of Immunology, Vol 149, Issue 8 2742-2748, Copyright © 1992 by American Association of Immunologists

ARTICLES

Regulation of paf-acether receptor expression in human B cells

CM Nguer, O Pellegrini, P Galanaud, J Benveniste, Y Thomas and Y Richard
Institut National de la Sante et de la Recherche Medicale U 131, Clamart, France.

Paf-acether (paf) is a phospholipid cytokine alloted with potent inflammatory and immunoregulatory properties. Recent reports indicated that in human B cell lines, paf modulated both early and late activation events. In our study, we showed that four of six human B cell lines specifically bound [3H]paf irrespective of the stage of differentiation, the presence of EBV genome or cell surface phenotype. Binding was saturated and fit a one receptor model with a dissociation constant ranging from 1 to 6 nM and a number of sites per cell ranging from approximately equal to 4000 in Rjc13 to approximately equal to 30,000 in Raji or IM9. In addition, our data indicate that 1) maximal expression occurred during the log phase growth; 2) paf itself (10-100 nM) or rIL-4 (100 U/ml) up-regulated by two- to threefold the number of paf binding sites without affecting the affinity. Finally, we found that activated normal B lymphocytes exhibited a higher capacity than resting B cells to incorporate and metabolize [3H]paf at 37 degrees C. Resting B lymphocytes lacked specific binding capacity for paf, yet specific paf receptors were induced upon stimulation via Staphylococcus aureus Cowan I or phorbol 12,13 dibutyrate plus ionomycin. These results suggest that B cell activation is a critical event for paf receptor expression and modulation.


This article has been cited by other articles:


Home page
 J. Immunol.Home page
Y. Matsumura, S. N. Byrne, D. X. Nghiem, Y. Miyahara, and S. E. Ullrich
A Role for Inflammatory Mediators in the Induction of Immunoregulatory B Cells
J. Immunol., October 1, 2006; 177(7): 4810 - 4817.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. T. Strait, S. C. Morris, K. Smiley, J. F. Urban Jr., and F. D. Finkelman
IL-4 Exacerbates Anaphylaxis
J. Immunol., April 1, 2003; 170(7): 3835 - 3842.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
B. Dubois, C. Massacrier, and C. Caux
Selective attraction of naive and memory B cells by dendritic cells
J. Leukoc. Biol., October 1, 2001; 70(4): 633 - 641.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Q. Zhuang, Y. Bastien, and B. D. Mazer
Activation Via Multiple Signaling Pathways Induces Down-Regulation of Platelet-Activating Factor Receptors on Human B Lymphocytes
J. Immunol., September 1, 2000; 165(5): 2423 - 2431.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1992 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1992 by The American Association of Immunologists, Inc. All rights reserved.